Kennedy Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Kennedy Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-46,040	Closed	-$5.29M	–	793
2014 Q4	$5.29M	Buy	46,040 +17,887	+64%	+$2.17M	0.1%	384
2014 Q3	$4.4M	Sell	28,153 -39,805	-59%	-$5.77M	0.09%	399
2014 Q2	$8.38M	Sell	67,958 -61,651	-48%	-$6.81M	0.16%	243
2014 Q1	$13.4M	Sell	129,609 -38,196	-23%	-$3.91M	0.25%	121
2013 Q4	$15.1M	Sell	167,805 -40,673	-20%	-$3.24M	0.28%	96
2013 Q3	$13.9M	Buy	208,478 +21,574	+12%	+$1.49M	0.27%	94
2013 Q2	$12.4M	Buy	+186,904	New	+$10.7M	0.25%	123

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kennedy Capital Management's SLXP Position: Q1 2015 in Review

Kennedy Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 46,040 shares — an estimated $5.29M sold.

Kennedy Capital Management first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $15.1M in Q4 2013. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

Kennedy Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
Kennedy Capital Management sold 46,040 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $5.29M.
Kennedy Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
Kennedy Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $15.1M in Q4 2013.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Kennedy Capital Management's 13F filing for Q1 2015, filed 7 May 2015.